本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.3200
-0.0183-5.41%
盘后0.33940.0194+6.06%16:59 EDT
成交量:185.48万
成交额:63.17万
市值:4,530.42万
市盈率:-1.05
高:0.3535
开:0.3490
低:0.3193
收:0.3383
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

SEC问询函

Form CORRESP - Correspondence
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/22

SEC问询函

Form CORRESP - Correspondence
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities